Nuclear medicine imaging is experiencing a technology renaissance driven by long axial field of view PET/CT systems enabling total-body PET imaging, new silicon photomultiplier detector technology dramatically improving sensitivity and time-of-flight resolution, and the emergence of theranostics creating an urgent clinical need for high-quality PET/CT imaging of theranostic targets. Siemens Healthineers' Biograph Vision Quadra with 106 cm axial field of view is the leading total-body PET/CT system globally.
This report provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs.
Topics Covered
• Long Axial Field of View PET
• CT
• Silicon Photomultiplier Detectors
• Time-of-Flight PET
• SPECT
• CT Technology
• Theranostics Imaging Requirements
• Digital PET Technology
• Competitive Landscape
Table of Contents
1. Executive Summary
2. Technology Landscape Overview
3. Long Axial Field of View PET
4. CT
5. Silicon Photomultiplier Detectors
6. Time-of-Flight PET
7. SPECT
8. CT Technology
9. Theranostics Imaging Requirements
10. Digital PET Technology
11. Competitive Landscape
12. Competitive Landscape
13. Strategic Conclusions and Recommendations
14. Appendix
List of Tables
Table 1. Technology Overview and Key Data 2025
Table 2. Long Axial Field of View PET
Table 3. CT
Table 4. Silicon Photomultiplier Detectors
Table 5. Time-of-Flight PET
Table 6. SPECT
Table 7. CT Technology
Table 8. Theranostics Imaging Requirements
Table 9. Digital PET Technology
Table 10. Competitive Landscape
Table 11. Leading Companies — Technology Investment and Strategy 2025
Table 12. M&A and Partnership Activity 2023-2025
Table 13. Key Risks and Mitigation Strategies
Companies Profiled
Bayer
Cardinal Health
GE HealthCare
Lantheus
Novartis AAA
POINT Biopharma
Siemens Healthineers
